Male circumcision and serologically determined human papillomavirus infection in a birth cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 1, 2009, Pages 177-183

  Dickson, Nigel P ^a,c   Ryding, Janka ^b   Van Roode, Thea ^a   Paul, Charlotte ^a   Herbison, Peter ^a   Dillner, Joakim ^b   Skegg, David C G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CIRCUMCISION; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORALITY; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALITY;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CIRCUMCISION, MALE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENITALIA, MALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; NEW ZEALAND; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; QUESTIONNAIRES; RISK FACTORS;

EID: 58349091479     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0353     Document Type: Article

References (50)

1. Skegg DCG, Corwin PA, Paul C, Doll R. Importance of the male factor in cancer of the cervix. Lancet 1982;2:581-3.
2. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
3. Circumcision and cervical cancer. BMJ 1964;2:397.
4. Hochman A, Ratzkowski E, Schreiber H. Incidence of carcinoma of the cervix in Jewish women in Israel. Br J Cancer 1955;9:358-64.
5. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973;33:1353-67.
6. Castellsagué X, Bosch FX, Muñoz F, et al. Circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105-12.
7. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004;31:601-7.
8. Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002;78:215-8.
9. Lajous M, Mueller N, Cruz-Valdez A, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005;14:1710-6.
10. Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, et al. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 2006;119:1934-9.
11. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004;189:677-85.
12. Shin HR, Franceschi S, Vaccarella S, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004;190:468-76.
13. Nielson CM, Harris RB, Dunne EF, et al. Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007;196:1137-45.
14. Dillner J. The serological response to papillomaviruses. Semin Cancer Biol 1999;9:423-30.
15. Kjellberg L, Wang Z, Wiklund F, et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol 1999;80:391-8.
16. Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 Infection in the United States. J Infect Dis 2002;186:1396-402.
17. Dillner J, Kallings I, Brihmer C, et al. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996;173:1394-8.
18. Svare EI, Kjaer SK, Nonnenmacher B, et al. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. J Infect Dis 1997;176:876-83.
19. Ryding J, French KM, Nauclera P, Barnabasc RV, Garnett GP, Dillner J. Seroepidemiology as basis for design of a human papillomavirus vaccination program. Vaccine 2008;26:5263-8.
20. Shah KV, Viscidi RP, Alberg AJ, Helzlsouer KJ, Comnstock GW. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. Cancer Epidemiol Biomarkers Prev 1997;6:233-7.
21. Geijersstam V, Kibur M, Wang Z, et al. Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis 1998;177:1710-4.
22. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006;110:525-41.
23. Silva PA, McCann M. An introduction to the Dunedin Study. In: Silva PA, Stanton WR, editors. From child to adult: The Dunedin Multidisciplinary Health and Development Study. Auckland: Oxford University Press; 1996. p. 1-23.
24. Johnson AM, Wadsworth J, Wellings K, Field J, Bradshaw S. Sexual attitudes and lifestyles. Oxford: Blackwell Scientific; 1994.
25. Elley WB, Irving JC. Revised socio-economic index for New Zealand. NZ J Educ Stud 1976;11:25-56.
26. Galbraith C, Jenkin G, Davis P, Coope P. New Zealand Socioeconomic Index 1996 Users' Guide. Wellington: Statistics New Zealand; 2003.
27. Moos RH. Family Environment Scale (Form R). Palo Alto (CA): Consulting Psychologists Press; 1974.
28. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000;243:243-55.
29. Grabowska K, Wang X, Jacobsson A, Dillner J. Evaluation of cost-precision ratios of different strategies for ELISA measurement of serum antibody levels. J Immunol Methods 2002;271:1-15.
30. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
31. Salmond GC. Maternal and infant care in Wellington a health care consumer study. Special report No. 45. Wellington: Department of Health; 1975.
32. Fergusson DM, Boden JM, Horwood LJ. Circumcision status and risk of sexually transmitted infection in young adult males: an analysis of a longitudinal birth cohort. Pediatrics 2006;118:1971-7.
33. McGrath K, Young H. A Review of Circumcision in New Zealand. In: Denniston GC, Hodges FM, Milos MF, editors. Understanding circumcision: A multi-disciplinary approach to a multi- dimensional problem. New York: Kluwer/Plenum; 2001. p. 129-46.
34. Dickson NP, van Roode T, Herbison P, Paul C. Circumcision and risk of sexually transmitted infections in a birth cohort. J Pediatr 2008;152:383-7.
35. Dickson NP, van Roode T, Paul C. HSV-2 status at age 26 is not related to early circumcision in a birth cohort. Sex Transm Dis 2005;32:517-9.
36. Xu F, Markowitz LE, Sternberg MR, Aral SE. Prevalence of circumcision and herpes simplex virus type 2 Infection in men in the United States: The National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis 2007;34:479-84.
37. Laumann EO, Masi CM, Zuckerman EW. Circumcision in the United States. Prevalence, prophylactic effects, and sexual practice. JAMA 1997;277:1052-7.
38. Dave SS, Johnson AM, Fenton KA, Mercer CH, Erens B, Wellings K. Male circumcision in Britain: findings from a national probability sample survey. Sex Trans Infect 2003;79:499-500.
39. Richters J, Smith AMA, de Visser RO, Grulich AE, Rissel CE. Circumcision in Australia: prevalence and effect on sexual health. Int J STD AIDS 2006;17:547-54.
40. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006;194:1044-57.
41. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006;6:21-31.
42. Agerkrout EM, Galloway DA. The humoral immune response to human papilloamavirus. In: Garcea RL, DiMaio D, editors. New York: Springer; 2007. p. 277-312.
43. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
44. Fox PA. Human papillomavirus and anal intraepithelial neoplasia. Curr Opin Infect Dis 2006;19:62-6.
45. Clifford GM, Shin H-R, Oh J-K, et al. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev 2007;16:1874-9.
46. Van Howe RS. Human papillomavirus and circumcision: a meta-analysis. J Infect 2007;54:490-6.
47. Castellsague X, Albero G, Cleries R, Bosch FX. HPV and circumcision: A biased, inaccurate and misleading meta-analysis. J Infect 2007;55:91-3.
48. Agarwal SS, Sehgal A, Sardana S, Kumar A, Luthra UK. Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer 1993;72:1666-9.
49. Brinton LA, Reeves WC, Brenes MM, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 1989;44:199-203.
50. Kjaer SK, de Villiers EM, Dahl C, et al. Case-control study of risk factors for cervical neoplasia in Denmark. I. Role of the "male factor" in women with one lifetime sexual partner. Int J Cancer 1991;48:39-44.